Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin

J Clin Endocrinol Metab. 1989 Mar;68(3):535-41. doi: 10.1210/jcem-68-3-535.

Abstract

The half-life (t1/2) of disappearance of endogenous GH from serum was studied using physiological effectors to stimulate and then suppress GH release. GH secretion was stimulated by a single iv injection of GHRH, followed 45 min later by an iv bolus dose and then a 2.5-h infusion of somatostatin (SRIH) to suppress further release. The in vivo t1/2 of GH in seven men was calculated from serum GH concentrations measured at frequent intervals after beginning the SRIH infusion. The mean t1/2 of endogenous GH was 18.9 +/- 0.8 (+/- SE) min by monoexponential analysis and 3.5 +/- 0.7 and 20.7 +/- 0.7 min by biexponential fitting. In these normal men, the decline in GH concentrations after GHRH and SRIH administration was similar to that after the administration of GHRH alone, which yielded a t1/2 of 20.3 +/- 1.9 min. We conclude that the physiological kinetics of endogenous GH removal/disappearance can be estimated in vivo in man using GHRH with or without SRIH infusion.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Growth Hormone / antagonists & inhibitors
  • Growth Hormone / metabolism*
  • Growth Hormone-Releasing Hormone / antagonists & inhibitors
  • Growth Hormone-Releasing Hormone / pharmacology*
  • Half-Life
  • Humans
  • Infusions, Intravenous
  • Male
  • Somatostatin / pharmacology*

Substances

  • Somatostatin
  • Growth Hormone
  • Growth Hormone-Releasing Hormone